Global Pharmacogenomics (PGx) Market Expected to Witness a Sustainable Growth over 2025

The latest research report"Global Pharmacogenomics (PGx) Market Growth 2025-2031" studied by LP Information offers a comprehensive overview of thePharmacogenomics (PGx) market, providing insights into its drivers, restraints, and future trends. This study utilizes a comprehensive and thorough research methodology to provide an objective perspective on the global Pharmacogenomics (PGx) industry, helping decision-makers make informed business decisions.

According to the report "Global Pharmacogenomics (PGx) Market Growth Trends 2025-2031" published by LP Information, the global Pharmacogenomics (PGx) market size is projected to be approximately 9083 million dollars in 2024, expecting to reach 17080 million dollars by 2031, with a compound annual growth rate (CAGR) of 9.6% % from 2025 to 2031.

Get the sample copy of the report:https://www.lpinformationdata.com/reports/1706443/pharmacogenomics--pgx

The chapter summaries of the Pharmacogenomics (PGx) report are as follows:
Chapter 1: Introducing the research scope of the Pharmacogenomics (PGx) report, including product definition, statistical year, research objectives and methods, research process and data sources, economic indicators and policy factors.
Chapter 2: In-depth study of the global market size of Pharmacogenomics (PGx), including the scale of product classification and application, including key indicators such as sales volume, revenue, price, market share, etc.
Chapter 3: Focus on the main competitive dynamics of the global Pharmacogenomics (PGx) market, sales, revenue, market share, pricing strategies, product types and geographical distribution of major players, industry concentration, potential entrants, mergers and acquisitions, and capacity expansion.
Chapter 4: Analyze the market size of Pharmacogenomics (PGx) in major regions around the world, including sales volume, revenue and growth rate.
Chapter 5: Explore the industry size and various applications of Pharmacogenomics (PGx) in the Americas, and introduce its sales volume and revenue in detail.
Chapter 6: Focus on the industry size and various applications of Pharmacogenomics (PGx) in the Asia-Pacific region, focusing on its sales volume and revenue.
Chapter 7: Analyze the industry size and specific applications of Pharmacogenomics (PGx) in Europe, and focus on its sales volume and revenue.
Chapter 8: In-depth exploration of the industry size and various applications of Pharmacogenomics (PGx) in the Middle East and Africa, and in-depth understanding of its sales volume and revenue.
Chapter 9: Analyze the development trends, drivers, challenges and risks of the Pharmacogenomics (PGx) industry.
Chapter 10: Explore the raw materials, suppliers, production costs, manufacturing processes and related supply chains used by Pharmacogenomics (PGx).
Chapter 11: Study the sales channels, distributors and downstream customers of the Pharmacogenomics (PGx) industry.
Chapter 12: Forecast the global market size of Pharmacogenomics (PGx) in different regions and product types, including sales volume, revenue and other related indicators.
Chapter 13: Detailed introduction of the major manufacturers in the Pharmacogenomics (PGx) market, including their basic information, product specifications and applications, sales volume, revenue, pricing, gross margin, core business and latest developments.
Chapter 14: Research Findings and Conclusion

Regions Covered in the GlobalPharmacogenomics (PGx) Market:
America (United States, Canada, Mexico,Brazil)
Europe (Germany, U.K., France, Italy, Russia, and Rest of Europe)
Asia-Pacific (China, India, Japan, Korea, Australia, Southeast Asia and Rest of Asia Pacific)
The Middle East and Africa (GCC Countries,Egypt, Israel,Turkey,South Africa and Rest of the Middle East & Africa)

Key Players in the Pharmacogenomics (PGx) Market
Abbott Laboratories
Affymetrix, Inc.
Assurex Health, Inc
Astrazeneca
GeneDX
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
Pathway Genomics
Pfizer, Inc
Qiagen, Inc.
Rocheg
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
Transgenomic, Inc.

The report published by LP Information provides a detailed analysis of the global Pharmacogenomics (PGx) market, including the following:

Industry Analysis: Covers raw materials, market applications, product types, market demand, market supply, upstream and downstream analysis, supply chain analysis, industry chain, and sales channel analysis.

Market Size Analysis: Includes data such as production capacity, production scale, sales figures, production value, price range, budgeted costs, and estimated profits. It also provides in-depth market research, sales data, market environment analysis, and market development forecasts. All information has been verified and audited to ensure accuracy.

Competitive Analysis: Covers profiles of major manufacturers, industry background, new entrant trends, mergers and acquisitions, expansions, market share, and opportunities and challenges.

Trend Analysis: Includes industry dynamics, growth drivers, development opportunities, favorable and unfavorable factors, industry policies, as well as development history, current status, and trends (including the market landscape over the past five years and development trends over the next six years).

Contact Us
LP INFORMATION
E-mail: info@lpinformationdata.com
Tel: +852-58080956(HK)/+86-177 2819 6195(CN)
Add: 17890 Castleton St. Suite 162 City of Industry, CA 91748 US
Website: https://www.lpinformationdata.com

This release was published on openPR.